BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25817518)

  • 1. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.
    Siedhoff MT; Wheeler SB; Rutstein SE; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL
    Am J Obstet Gynecol; 2015 May; 212(5):591.e1-8. PubMed ID: 25817518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy.
    Hur HC; King LP; Klebanoff MJ; Hur C; Ricciotti HA
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():122-127. PubMed ID: 26520875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
    Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
    Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
    Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic hysterectomy: weigh harms, but do not dismiss benefits.
    Nygaard I
    Am J Obstet Gynecol; 2015 May; 212(5):553-5. PubMed ID: 25925627
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.
    Wright JD; Cui RR; Wang A; Chen L; Tergas AI; Burke WM; Ananth CV; Hou JY; Neugut AI; Temkin SM; Wang YC; Hershman DL
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26449386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Morcellation Hysterectomy for Myomas.
    Bortoletto P; Einerson BD; Miller ES; Milad MP
    J Minim Invasive Gynecol; 2015; 22(5):820-6. PubMed ID: 25827327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Factors That Predict the Need to Morcellate in Total Laparoscopic Hysterectomy.
    Wolfe M; Biest S; Tutlam N; Woolfolk C; Winner B
    J Minim Invasive Gynecol; 2018 Jan; 25(1):158-162. PubMed ID: 28943192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in uterine fibroid tissue extraction.
    Cohen SL; Hariton E; Afshar Y; Siedhoff MT
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):277-82. PubMed ID: 27253236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
    Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
    J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
    Chen I; Hopkins L; Firth B; Boucher J; Singh SS
    J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up.
    Boruta DM; Shibley T
    J Minim Invasive Gynecol; 2016; 23(6):1009-11. PubMed ID: 27393286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.